Literature DB >> 11470311

Iron and neurodegenerative disorders.

K J Thompson1, S Shoham, J R Connor.   

Abstract

The brain shares with other organs the need for a constant and readily available supply of iron and has a similar array of proteins available to it for iron transport, storage, and regulation. However, unlike other organs, the brain places demands on iron availability that are regional, cellular, and age sensitive. Failure to meet these demands for iron with an adequate supply in a timely manner can result in persistent neurological and cognitive dysfunction. Consequently, the brain has developed mechanisms to maintain a continuous supply of iron. However, in a number of common neurodegenerative disorders, there appears to be an excess accumulation of iron in the brain that suggests a loss of the homeostatic mechanisms responsible for regulating iron in the brain. These systems are reviewed in this article. As a result of a loss in iron homeostasis, the brain becomes vulnerable to iron-induced oxidative stress. Oxidative stress is a confounding variable in understanding the cell death that may result directly from a specific disease and is a contributing factor to the disease process. The underlying pathogenic event in oxidative stress is cellular iron mismanagement.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470311     DOI: 10.1016/s0361-9230(01)00510-x

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  52 in total

1.  Recovery of motor deficit, cerebellar serotonin and lipid peroxidation levels in the cortex of injured rats.

Authors:  Antonio Bueno-Nava; Rigoberto Gonzalez-Pina; Alfonso Alfaro-Rodriguez; Vladimir Nekrassov-Protasova; Alfredo Durand-Rivera; Sergio Montes; Fructuoso Ayala-Guerrero
Journal:  Neurochem Res       Date:  2010-06-10       Impact factor: 3.996

Review 2.  Redox control of prion and disease pathogenesis.

Authors:  Neena Singh; Ajay Singh; Dola Das; Maradumane L Mohan
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

Review 3.  Headache and ADHD in Pediatric Age: Possible Physiopathological Links.

Authors:  Maria Chiara Paolino; Alessandro Ferretti; Maria Pia Villa; Pasquale Parisi
Journal:  Curr Pain Headache Rep       Date:  2015-07

4.  Differential effect of nimodipine in attenuating iron-induced toxicity in brain- and blood-brain barrier-associated cell types.

Authors:  J A Lockman; W J Geldenhuys; K A Bohn; S F Desilva; D D Allen; C J Van der Schyf
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

5.  A role for iron and oxygen chemistry in preserving soft tissues, cells and molecules from deep time.

Authors:  Mary H Schweitzer; Wenxia Zheng; Timothy P Cleland; Mark B Goodwin; Elizabeth Boatman; Elizabeth Theil; Matthew A Marcus; Sirine C Fakra
Journal:  Proc Biol Sci       Date:  2013-11-27       Impact factor: 5.349

6.  Increased serum ferritin levels in amyotrophic lateral sclerosis (ALS) patients.

Authors:  E F Goodall; M S Haque; K E Morrison
Journal:  J Neurol       Date:  2008-07-18       Impact factor: 4.849

7.  Plasma trace elements and cognitive function in older men and women: the Rancho Bernardo study.

Authors:  P K Lam; D Kritz-Silverstein; E Barrett Connor; D Milne; F Nielsen; A Gamst; D Morton; D Wingard
Journal:  J Nutr Health Aging       Date:  2008-01       Impact factor: 4.075

Review 8.  Iron and intracerebral hemorrhage: from mechanism to translation.

Authors:  Xiao-Yi Xiong; Jian Wang; Zhong-Ming Qian; Qing-Wu Yang
Journal:  Transl Stroke Res       Date:  2013-12-21       Impact factor: 6.829

9.  Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging.

Authors:  Y Ge; J H Jensen; H Lu; J A Helpern; L Miles; M Inglese; J S Babb; J Herbert; R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.